DIA445.22+2.86 0.65%
SPX6,297.36+33.66 0.54%
IXIC20,885.65+155.16 0.75%

21 Stocks Moving in Friday's Pre-Market Session

Gainers Blackboxstocks Inc. (NASDAQ: BLBX) rose 37.6% to $3.69 in pre-market trading after the company reported better-than-expected Q4 sales results.
Benzinga·04/01/2022 11:09:03
Listen to the news

Gainers

  • Blackboxstocks Inc. (NASDAQ:BLBX) rose 37.6% to $3.69 in pre-market trading after the company reported better-than-expected Q4 sales results.
  • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) rose 21.3% to $9.69 in pre-market trading after reporting Q4 results.
  • Exela Technologies, Inc. (NASDAQ:XELA) shares rose 19.3% to $0.4964 in pre-market trading after the company reported CEO transition effective April 2022.
  • Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) rose 16.5% to $7.90 in pre-market trading following Q4 results.
  • GameStop Corp. (NYSE:GME) rose 15.3% to $192.00 in pre-market trading after the company announced a plan to request stockholder approval for an increase in the number of authorized shares of Class A common stock from 300 million to 1 billion in order to implement a stock split.
  • Meiwu Technology Company Limited (NASDAQ:WNW) rose 10.3% to $0.97 in pre-market trading after dropping 22% on Thursday.
  • DiDi Global Inc. (NYSE:DIDI) rose 9.5% to $2.74 in pre-market trading after declining 15% on Thursday.
  • iSun, Inc. (NASDAQ:ISUN) rose 9.5% to $4.49 in pre-market trading. iSun recently said it will reschedule the release of its results for fourth quarter and full-year 2021.
  • Comstock Mining Inc. (NYSE:LODE) rose 8.4% to $1.81 in pre-market trading. Comstock Mining recently posted FY21 results.
  • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) shares rose 8.7% to $0.2516 in pre-market trading. Allena Pharmaceuticals recently said it would terminate its URIROX-2 Study to reduce kidney stone disease progression.
  • Vertex Energy, Inc. (NASDAQ:VTNR) rose 7.4% to $10.68 in pre-market trading after jumping 15% on Thursday.


Don’t forget to check out our premarket coverage here .

Losers

  • Redwire Corporation (NYSE:RDW) shares fell 24.7% to $6.38 in pre-market trading after the company reported FY21 earnings results and issued FY22 sales guidance.
  • ARCA biopharma, Inc. (NASDAQ:ABIO) fell 23.9% to $1.75 in pre-market trading after the company said results from Phase 2 trial of ASPEN-COVID did not meet primary endpoint.
  • Blend Labs, Inc. (NYSE:BLND) shares fell 21.1% to $4.50 in pre-market trading after the company reported worse-than-expected Q4 sales results and issued both Q1 and FY22 sales guidance below analyst estimates.
  • 4D pharma plc (NASDAQ:LBPS) fell 13.7% to $4.17 in pre-market trading as the company posted a FY21 net loss of $32.1 million.
  • Reed's, Inc. (NYSE:REED) fell 9.2% to $0.2730 in pre-market trading as the company reported fourth-quarter revenue growth of 20% year-over-year to $12.8 million, missing the consensus of $13.02 million.
  • Digital Brands Group, Inc. (NASDAQ:DBGI) shares fell 8.4% to $1.74 in pre-market trading as the company posted a wider quarterly loss.
  • Blue Water Vaccines, Inc. (NASDAQ:BWV) fell 8% to $52.00 in pre-market trading after gaining 5% on Thursday.
  • Wejo Group Limited (NASDAQ:WEJO) shares fell 7.9% to $3.72 in pre-market trading after the company reported FY21 EPS results were lower year over year.
  • Longeveron Inc. (NASDAQ:LGVN) fell 7.5% to $12.77 in pre-market trading. Longeveron shares jumped 105% on Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with mild Alzheimer's disease in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
  • COMSovereign Holding Corp. (NASDAQ:COMS) fell 7.1% to $0.78 in pre-market trading after declining around 9% on Thursday.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.